BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35159386)

  • 1. Long non-coding RNAs involved in cancer metabolic reprogramming.
    Liu H; Luo J; Luan S; He C; Li Z
    Cell Mol Life Sci; 2019 Feb; 76(3):495-504. PubMed ID: 30341461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs and their possible roles in tumorigenesis and drug resistance in cancer chemotherapy.
    Ali ES; Yalın AE; Yalın S
    Nucleosides Nucleotides Nucleic Acids; 2024 Apr; ():1-15. PubMed ID: 38575568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.
    Chen W; Geng D; Chen J; Han X; Xie Q; Guo G; Chen X; Zhang W; Tang S; Zhong X
    Cancer Cell Int; 2024 Mar; 24(1):101. PubMed ID: 38462618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
    Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
    Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutically actionable long non-coding RNA '
    Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
    Res Sq; 2023 Dec; ():. PubMed ID: 38077055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis.
    Hong A; Cao M; Li D; Wang Y; Zhang G; Fang F; Zhao L; Wang Q; Lin T; Wang Y
    Carcinogenesis; 2023 Dec; 44(12):871-883. PubMed ID: 37843471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway.
    Zhang Z; Zhang D; Wang F; Liu J; Sun Y; Anuchapreeda S; Tima S; Xiao Z; Duangmano S
    PeerJ; 2023; 11():e15172. PubMed ID: 37096066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Motin family proteins in tumorigenesis-an update.
    Amirifar P; Kissil J
    Oncogene; 2023 Apr; 42(16):1265-1271. PubMed ID: 36973516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2.
    Zhang G; Wang Z; Liu J; Feng S; Ji S; Ai D
    Open Med (Wars); 2023; 18(1):20230628. PubMed ID: 36874361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HAGLR May Aggravate Melanoma Malignancy Via miR-4644/ASB11 Pathway.
    Luo L; Zhang W; Li Z
    Mol Biotechnol; 2023 Oct; 65(10):1619-1631. PubMed ID: 36735150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
    Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
    Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.
    Maimaitiyiming Y; Ye L; Yang T; Yu W; Naranmandura H
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.
    Melixetian M; Pelicci PG; Lanfrancone L
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
    PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis.
    Najafi S; Khatami SH; Khorsand M; Jamali Z; Shabaninejad Z; Moazamfard M; Majidpoor J; Aghaei Zarch SM; Movahedpour A
    Exp Cell Res; 2022 Sep; 418(2):113294. PubMed ID: 35870535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical roles of lncRNAs in the pathogenesis of melanoma.
    Safa A; Gholipour M; Dinger ME; Taheri M; Ghafouri-Fard S
    Exp Mol Pathol; 2020 Dec; 117():104558. PubMed ID: 33096077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
    Richtig G; Ehall B; Richtig E; Aigelsreiter A; Gutschner T; Pichler M
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350340
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.